Login / Signup
Does the FDA-approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?
Andrew Gleason
Scott Ayton
Ashley I Bush
Published in:
The Medical journal of Australia (2022)
Keyphrases
</>
drug administration
cognitive decline
adverse drug
drug induced